［1］ Imhof S M, Mourits M P, Hofman P,et al. Quantification of orbital and midfacial growth retardation after megavoltage external beam irradiation in children with retinoblastoma［J］. Ophthalmology,1996,103(2):263-268.

［2］ Peylan-Ramu N, Bin-Nun A,Skleir-Levy M, et al. Orbital growth retardation in retinoblastoma survivors: work in progress［J］. Med Pediatr Oncol, 2001,37(5):465-470.

［3］ Abramson D H, Frank C M. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation related risk［J］. Ophthalmology,1998,105(4):573-579.

［4］ Munier F L, Verwey J, Pica A, et al. New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques［J］. Clin Experiment Ophthalmol,2008,36(1):78-89.

［5］ Shields C L, Honavar S G, Meadows A T,et al. Chemoreduction plus focal therapy for retinoblastoma : factors predictive of need for treatment with external beam radiotherapy or enucleation［J］. Am J Ophthalmol,2002,133(5):657-664.

［6］ Kaan G, Ilhan G, Nilufer Y, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation［J］. Ophthalmology, 2004,111(10):1917-1924.

［7］ Chan M Y, Hungerford J L, Kingston J E, et al. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma : rate of eye and vision preservation［J］. Br J Ophthalmol, 2009,93(7):891-894.

［8］ Shields C L，Ramasubramanian A,Thangappan A, et al. Chemoreduction for group e Retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes［J］. Ophthalmology，2009,116(3):544-551.

［9］ Sahgal A, Millar B A, Michaels H, et al. Focal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results［J］. Clinical Oncology,2006,18(8):628-634.

［10］ Pica A, Moeckli R, Balmer A, et al.Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complication after treatment with linear accelerator-based sterotactic radiotherapy with micromultileaf collimator as second-line or salvage treatment after chemotherapy［J］. Int J Radiat Oncol Biol Phys,2010,67(3):1-7.

［11］ Krasin M J, Crawford B T, Zhu Y, et al. Intensity-modulated Radiation therapy for children with intraocular retinoblastoma: potential sparing of the bone orbit［J］. Clin Oncol,2004,16(3):215-222.

［12］ Reisner M L, Viegas C P, Grazziotin R Z, et al. Retinoblastoma — comparative analysis of external radiotherapy techniques, including an IMRT technique［J］. Int J Radiat Oncol Biol Phys,2007,67(3):933-941.

［13］ Eldebawy E, Parker M, Rahman W A, et al. Dosimetric study of current treatment options for radiotherapy in retinoblastoma［J］. Int J Radiat Oncol Biol Phys,2012,82(3):e501-e505.

［14］ Lee C T, Bilton S D, Famiglietti R M, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma : how do protons compare with other conformal techniques ?［J］. Int J Radiat Oncol Biol Phys,2005,63(2):362-372.

［15］ Krengli M, Hug E B, Adams J A, et al. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements［J］. Int J Radiat Oncol Biol Phys,2005,61(2):583-593.

［16］ Chang J W, Yu Y S, Kim J Y, et al. The clinical outcomes of proton beam radiation therapy for retinoblastomas that were resistant to chemotherapy and focal treatment［J］. Korean J Ophthalmol,2011,25(6):387-393.